Klinrisk
Predicting Risk to Prevent Chronic Disease Progression
- Headquarters
- Alberta
- Business Model
- B2B
- Website
- klinrisk.com
- Last Round
- GrantJan 2023
- Rounds
- 1
About
Klinrisk is an AI-enabled clinical diagnostics company that develops lab-based risk prediction tools for chronic disease, with its flagship product identifying progressive kidney disease before kidney function is lost. Its machine learning algorithm analyzes routinely collected blood and urine lab data to generate a Klinrisk Score, enabling clinicians to detect CKD progression earlier than standard measures and guide treatment decisions proactively. The company partners with major healthcare and pharmaceutical organizations including LifeLabs, Eli Lilly, and Bayer, and its Klinrisk Score has been recognized in the KDIGO 2024 CKD Clinical Practice Guideline.
Summary
Klinrisk is a Healthcare company based in Canada. Its most recent funding was a Grant round in Jan 2023. Investors include National Kidney Foundation.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2023
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
China's leading blood products manufacturer
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...